Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.095 CAD | 0.00% | -20.83% | -47.22% |
Apr. 25 | Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call | |
Mar. 22 | Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.22% | 6.84M | |
+26.03% | 653B | |
+27.00% | 556B | |
-6.55% | 354B | |
+20.38% | 331B | |
+2.65% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.31% | 144B |
- Stock Market
- Equities
- VPH Stock
- News Valeo Pharma Inc.
- Valeo Pharma Brief: Reporting Fifth consecutive quarter of revenue growth at $13.2 million in Q1-23, up 210% over Q1-22; Fifth consecutive quarter of adjusted EBITDA loss reduction at $2.2 million, a 51% improvement over Q1-22